Dr. Dilip Samarapungavan, MD

  • Royal Oak, MI
  • Nephrologist
NPI1689635955PAC ID7618932187
Medicare services, 2024
273
Medicare patients, 2024
162
Part D claims, 2024
1,787
Publications
10
Clinical trials
1
Practice address
3601 W Thirteen Mile Rd, Royal Oak, MI 48073
Practice phone
Call (248) 898-5400
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Find Dr. Samarapungavan's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Dilip Samarapungavan is a nephrologist in Royal Oak, Michigan

Dr. Samarapungavan practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health.

Dr. Samarapungavan's NPI, 1689635955, was assigned on March 28, 2006. Dr. Samarapungavan holds Michigan license 4301065266.

NPI and contact details
Medicare PAC ID
7618932187
NPI enumeration date
March 28, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(248) 898-5400
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
64
Medical school graduation
1988

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Dilip Samarapungavan practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan

Dr. Samarapungavan's primary practice is Corewell Health William Beaumont University Hospital, at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 898-5400.

Source: Dmand AI Affiliation Data

Dr. Dilip Samarapungavan is affiliated with 7 sites of care and 2 medical groups

Dr. Samarapungavan's primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. Dr. Samarapungavan is also affiliated with Corewell Health Beaumont Troy Hospital. The medical group on file is Beaumont Medical Group - Specialty Services. Dmand AI also links Dr. Samarapungavan to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

See all 9 affiliations for Dr. Samarapungavan

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Dilip Samarapungavan's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Samarapungavan practices, 7 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Corewell Health William Beaumont University HospitalAvailable with a free account
+6 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Samarapungavan practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Corewell Health and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Dilip Samarapungavan is one of 310 nephrologists in Michigan

Nephrology is Dr. Samarapungavan's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Samarapungavan is licensed in Michigan.

Specialties and state licenses

  • Nephrology, MichiganPrimaryLicense 4301065266 · taxonomy 207RN0300X

Nephrologists near Dr. Samarapungavan

Counts of nephrologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Dilip Samarapungavan billed Medicare for 273 services in 2024

CMS data shows 273 Medicare services from Dr. Samarapungavan across 4 procedure codes in 2024, for 162 Medicare patients. Medicare paid $26,284 for them.

Medicare services, 2024273
Medicare patients162
Paid by Medicare$26,284
Procedure codes4

Dr. Samarapungavan's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 3532024: 27323%

Where Dr. Samarapungavan's Medicare services took place, 2024

  • In an office166%
  • In a facility25794%

Dr. Samarapungavan compared with the Michigan median for nephrologists, 2024

  • Dr. Samarapungavan
  • Michigan median
Medicare services
273vs 84968% below
Medicare patients
162vs 26940% below
Part D claims
1,523vs 5742.7 times

Medians across 310 nephrologists in Michigan with Dmand AI profiles that report each measure.

Dr. Samarapungavan's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Samarapungavan

Need commercial claims for Dr. Samarapungavan?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Samarapungavan and other nephrologists in Michigan.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Dilip Samarapungavan treated 162 Medicare patients in 2024, average age 62

CMS counts 162 Medicare patients who saw Dr. Samarapungavan in 2024. The largest group is under 65, with 88 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 27% are also on Medicaid. Their average risk score is 4.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Samarapungavan's median patient age at 60, with 46% women.

Medicare patients, 2024162
Average age62
Average risk score4.43
Also on Medicaid27%

Dr. Samarapungavan's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Samarapungavan's Medicare patients by sex, 2024

  • Women7848%
  • Men8452%

Chronic conditions among Dr. Samarapungavan's Medicare patients, 2024

  1. Chronic kidney disease75%
  2. High blood pressure75%
  3. High cholesterol75%
  4. Diabetes55%
  5. Arthritis35%
  6. Ischemic heart disease34%
  7. Heart failure27%
  8. Mood disorders25%

Share of Medicare patients with each condition. A patient can have several.

Dr. Samarapungavan's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 60

Patient panel by sex, all payers

  • Women46%
  • Men52%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Dilip Samarapungavan wrote 1,787 Medicare Part D claims in 2024

In 2024, Dr. Samarapungavan wrote 1,787 Medicare Part D claims for 232 patients. 96% of them were for generic drugs. CMS names the drug for 1,523 of them, across 32 drugs with 11 or more claims each, at $57,137 in total drug cost. In 2023, CMS named 1,656 claims across 33 drugs.

Part D claims, 20241,787
Drugs named by CMS32
Total drug cost$57,137
Part D patients232

Dr. Samarapungavan's Part D claims by kind of drug, 2024

  • Generic1,718 claims96%
  • Brand-name and other69 claims4%

Dr. Samarapungavan's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Samarapungavan's Part D claims, 2024

  • Antibiotics7%128 of 1,787 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1,6562024: 1,5238%

Drugs named by CMS: 32 in 2024, 33 in 2023.

See all prescribing by Dr. Samarapungavan

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Dilip Samarapungavan scored 84 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Samarapungavan for performance year 2024, reported as part of a group. Dr. Samarapungavan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Samarapungavan's MIPS scores, performance year 2024

  • 84of 100Final score
  • 66.7of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 71of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find nephrologists like Dr. Samarapungavan by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Dilip Samarapungavan has 10 publications on record

Dmand AI links 10 papers to Dr. Samarapungavan, published from 2011 to 2023. The most frequent topics are Kidney Transplantation, Biopsy and Kidney Diseases. Dr. Samarapungavan has published most often in Transplant Proc. Dr. Samarapungavan's most frequent co-authors are Steven R. Cohn, MD, Damanpreet Singh Bedi, MD and Alan Joseph Koffron, MD.

Papers10
Years published2011 to 2023

Dr. Samarapungavan's papers by year, 2011 to 2023

Topics Dr. Samarapungavan writes about most

  • Kidney Transplantation
  • Biopsy
  • Kidney Diseases
  • Kidney
  • Staining and Labeling
  • BK Virus
  • Graft Rejection
  • Polyomavirus Infections

Dr. Samarapungavan's most frequent co-authors

Recent publications by Dr. Samarapungavan

See all 10 publications and co-authors

See who Dr. Samarapungavan researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Samarapungavan works with, so you can find a warm path to the right nephrologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Dilip Samarapungavan has worked on 1 clinical trial

Dmand AI links Dr. Samarapungavan to 1 clinical trial.

Investigators on the most trials with Dr. Samarapungavan

Recent clinical trials with Dr. Samarapungavan

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Dilip Samarapungavan received $95 in industry payments in 2016

CMS Open Payments shows 1 general payment to Dr. Samarapungavan from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $95.

Companies that paid Dr. Samarapungavan the most, 2016 to 2016

Share is of all general payments to this clinician.

See all payments to Dr. Samarapungavan

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Dilip Samarapungavan's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Dilip Samarapungavan

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Dilip Samarapungavan's NPI number?

Dr. Dilip Samarapungavan's NPI number is 1689635955. It was assigned on March 28, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Dilip Samarapungavan?

Dr. Dilip Samarapungavan is a nephrologist in Royal Oak, Michigan. The primary specialty in the NPI Registry is Nephrology Physician (taxonomy code 207RN0300X).

Where does Dr. Dilip Samarapungavan practice?

Dr. Samarapungavan practices at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073. Dr. Samarapungavan's primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. Dmand AI also links Dr. Samarapungavan to 3 hospitals, 2 group practices and clinics and 1 medical group.

What is Dr. Dilip Samarapungavan's office phone number?

The practice phone on file for Dr. Samarapungavan is (248) 898-5400.

What is Dr. Dilip Samarapungavan's medical license number?

Dr. Samarapungavan holds Michigan license 4301065266.

Which hospitals is Dr. Dilip Samarapungavan affiliated with?

Dr. Samarapungavan practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan. Dr. Samarapungavan is also affiliated with Corewell Health Beaumont Troy Hospital. Dmand AI links Dr. Samarapungavan to 3 more hospitals.

What medical group is Dr. Dilip Samarapungavan part of?

Dr. Samarapungavan is linked to Beaumont Medical Group - Specialty Services. Dmand AI links Dr. Samarapungavan to 1 more medical group.

Does Dr. Dilip Samarapungavan accept Medicare?

Yes. CMS data shows Dr. Samarapungavan billed Medicare for 273 services in 2024, and Dr. Samarapungavan accepts Medicare assignment.

What is Dr. Dilip Samarapungavan's MIPS score?

Dr. Samarapungavan's MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.

How many Medicare patients does Dr. Dilip Samarapungavan see?

CMS counts 162 Medicare patients who saw Dr. Samarapungavan in 2024, with an average age of 62.

Show 6 more questionsShow fewer questions

What services does Dr. Dilip Samarapungavan bill to Medicare?

In 2024, Dr. Samarapungavan's most billed Medicare services were office visit, established patient (99215), office visit, established patient (99214) and hospital inpatient care (99233).

What drugs does Dr. Dilip Samarapungavan prescribe most?

In 2024 Medicare Part D data, Dr. Samarapungavan's most prescribed drugs by claims were Prednisone, Omeprazole and Nifedipine ER.

Has Dr. Dilip Samarapungavan received payments from drug or device companies?

CMS Open Payments shows $95 in general payments to Dr. Samarapungavan from 1 company from 2016 to 2016. The largest total came from Bristol-Myers Squibb Company.

How long has Dr. Dilip Samarapungavan been practicing?

Dr. Samarapungavan graduated from medical school in 1988, 38 years ago.

Does Dr. Dilip Samarapungavan do research?

Dmand AI links 10 publications to Dr. Samarapungavan, published from 2011 to 2023. Dr. Samarapungavan has worked on 1 clinical trial.

Who does Dr. Dilip Samarapungavan publish with?

Dr. Samarapungavan's most frequent co-authors are Steven R. Cohn, MD (4 shared papers), Damanpreet Singh Bedi, MD (3 shared papers) and Alan Joseph Koffron, MD (3 shared papers).

Selling to nephrology practices?

See nephrologists in Michigan by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)